| アイテムタイプ |
学術雑誌論文 / Journal Article(1) |
| 公開日 |
2025-06-23 |
| タイトル |
|
|
タイトル |
Combined Molecular Subclass and Immune Phenotype Correlate to Atezolizumab Plus Radiation Therapy Response in Invasive Bladder Cancer: BPT-ART Phase 2 Study. |
|
言語 |
en |
| 言語 |
|
|
言語 |
eng |
| 資源タイプ |
|
|
資源タイプ識別子 |
http://purl.org/coar/resource_type/c_6501 |
|
資源タイプ |
journal article |
| 著者 |
Yoshiyuki Nagumo
Kyosuke Hattori
Tomokazu Kimura
Yuta Sekino
Taku Naiki
Yasuyuki Kobayashi
Takashi Matsumoto
Takahiro Osawa
Yuki Kita
Masae Takemura
Bryan J Mathis
Susumu Suzuki
Toyonori Tsuzuki
Hitoshi Ishikawa
Hiroyuki Nishiyama
|
| 抄録 |
|
|
内容記述タイプ |
Abstract |
|
内容記述 |
Bladder preservation therapy in combination with atezolizumab and radiation therapy trial, which was a multicenter, open-label, single-arm phase 2 study, showed a promisingly high interim clinical complete response (cCR) rate of 84.4% (38/45). In the present study, we aimed to identify potential tissue biomarkers for achieving cCR using bladder preservation therapy in combination with atezolizumab and radiation therapy. |
| 書誌情報 |
International journal of radiation oncology, biology, physics
巻 122,
号 1,
p. 168-180,
発行日 2025-05
|
| 出版者 |
|
|
出版者 |
Elsevier, Inc |
| ISSN |
|
|
収録物識別子タイプ |
ISSN |
|
収録物識別子 |
1879-355X |
| PubMed番号 |
|
|
|
識別子タイプ |
PMID |
|
|
関連識別子 |
39755215 |
| DOI |
|
|
|
識別子タイプ |
DOI |
|
|
関連識別子 |
10.1016/j.ijrobp.2024.12.019 |
